Seth Klarman Gossamer Bio, Inc. Transaction History

Baupost Group LLC

  • $3.52 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020
SELL
$14.82 - $26.79 $14.3 Million - $25.9 Million
-967,171 Closed
0 $0
Q3 2019

Nov 13, 2019
SELL
$16.02 - $22.47 $4.81 Million - $6.74 Million
-300,000 Reduced 23.67%
967,171 $15.9 Million
Q1 2019

May 15, 2019
BUY
$17.58 - $23.97 $22.3 Million - $30.4 Million
1,267,171 New
1,267,171 $26.1 Million

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $81.7M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track Seth Klarman's Portfolio

Track Seth Klarman Portfolio

Follow Seth Klarman (Baupost Group LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baupost Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baupost Group LLC and Seth Klarman with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email